Menu Close

Older class of type 2 diabetes drugs, glitazones, linked to 22% reduction in dementia risk

Use of an older class of type 2 diabetes drugs called glitazones, also known as thiazolidinediones or TZDs for short, is linked to a 22% reduced risk of dementia, reveals a long term study published in the open access journal BMJ Open Diabetes Research & Care.